A Computational Approach for the Prediction of p53 and BCL-2 Protein-Protein Interactions

Area of Science:

• Molecular biology
• Computational biology
• Cancer research

Background:

• p53 is a key tumor suppressor regulating cellular pathways.
• p53's transcription activation domain (TAD) interacts with BCL-2, influencing cell survival and death.
• In vitro studies often use truncated p53, not reflecting natural cellular conditions.

Purpose of the Study:

• To simulate in silico the interaction of full-length wild-type (WT) and mutant (MT) p53 with BCL-2.
• To provide predictive insights into p53-BCL-2 interactions using established algorithms.
• To compare computational predictions with existing crystallographic data for validation.

Main Methods:

• Utilized pre-established computational techniques (in silico) to model p53-BCL-2 interactions.
• Compared simulated interactions with known crystal structures to validate the methodology.
• Predicted binding affinities between WT/MT p53 variants and BCL-2.

Main Results:

• The computational protocol successfully replicated known amino acid interactions between p53 and BCL-2.
• Identified binding affinities for interactions between WT/MT p53 and BCL-2.
• Predicted that most major MT p53 variants interact with BCL-2, but with reduced affinity compared to WT p53.

Conclusions:

• The developed in silico method can predict p53-BCL-2 interactions and binding affinities.
• Reduced affinity of MT p53 for BCL-2 suggests a potential increase in BCL-2's cell survival activity.
• This workflow can guide future in vitro and in vivo studies on p53 and BCL-2.